The antimicrobial protein S100A7/psoriasin enhances the expression of keratinocyte differentiation markers and strengthens the skin's tight junction barrier

British Journal of Dermatology

Volumn 171, Issue 4, 2014, Pages 742-753

  Hattori, F ^a,b   Kiatsurayanon, C ^a   Okumura, K ^a   Ogawa, H ^a   Ikeda, S ^a   Okamoto, K ^a,b   Niyonsaba, F ^a  

^a JUNTENDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Mikimoto Pharmaceutical Co Ltd   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CLAUDIN 1; CLAUDIN 14; CLAUDIN 3; CLAUDIN 4; CLAUDIN 7; CLAUDIN 9; FILAGGRIN; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA; INVOLUCRIN; LORICRIN; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PSORIASIN; TIGHT JUNCTION PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN; CADHERIN; DEXTRAN; DIFFERENTIATION ANTIGEN; FLUORESCEIN ISOTHIOCYANATE; GLYCOGEN SYNTHASE KINASE 3 ALPHA; GLYCOGEN SYNTHASE KINASE 3 BETA; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PROTEIN S 100; S100A7 PROTEIN, HUMAN;

ARTICLE; CELL CONTACT; CELL DIFFERENTIATION; CONFOCAL LASER MICROSCOPY; ELECTRIC RESISTANCE; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; ICHTHYOSIS VULGARIS; IMMUNOFLUORESCENCE MICROSCOPY; INNATE IMMUNITY; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; TRANSEPITHELIAL ELECTRICAL RESISTANCE; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; CELL CULTURE; DRUG EFFECTS; METABOLISM; SKIN; TIGHT JUNCTION;

ANTIGENS, DIFFERENTIATION; BETA CATENIN; CADHERINS; CELLS, CULTURED; DEXTRANS; FLUORESCEIN-5-ISOTHIOCYANATE; GLYCOGEN SYNTHASE KINASE 3; HUMANS; KERATINOCYTES; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; S100 PROTEINS; SKIN; TIGHT JUNCTION PROTEINS; TIGHT JUNCTIONS;

EID: 84936162311     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.13125     Document Type: Article

References (58)

1. Niyonsaba F, Nagaoka I, Ogawa H,. Human defensins and cathelicidins in the skin: beyond direct antimicrobial properties. Crit Rev Immunol 2006; 26: 545-76.
2. Niyonsaba F, Nagaoka I, Ogawa H, et al,. Multifunctional antimicrobial proteins and peptides: natural activators of immune systems. Curr Pharm Des 2009; 15: 2393-413.
3. Oppenheim JJ, Yang D,. Alarmins: chemotactic activators of immune responses. Curr Opin Immunol 2005; 17: 359-65.
4. Hancock RE, Chapple DS,. Peptide antibiotics. Antimicrob Agents Chemother 1999; 43: 1317-23.
5. Ridinger K, Ilg EC, Niggli FK, et al,. Clustered organization of S100 genes in human and mouse. Biochim Biophys Acta 1998; 1448: 254-63.
6. Vegfors J, Petersson S, Kovacs A, et al,. The expression of psoriasin (S100A7) and CD24 is linked and related to the differentiation of mammary epithelial cells. PLOS ONE 2012; 7: e53119.
7. Candi E, Schmidt R, Melino G,. The cornified envelope: a model of cell death in the skin. Nat Rev Mol Cell Biol 2005; 6: 328-40.
8. Eckert RL, Broome AM, Ruse M, et al,. S100 proteins in the epidermis. J Invest Dermatol 2004; 123: 23-33.
9. Jinquan T, Vorum H, Larsen CG, et al,. Psoriasin: a novel chemotactic protein. J Invest Dermatol 1996; 107: 5-10.
10. Niyonsaba F, Hattori F, Maeyama K, et al,. Induction of a microbicidal protein psoriasin (S100A7), and its stimulatory effects on normal human keratinocytes. J Dermatol Sci 2008; 52: 216-19.
11. Kirschner N, Rosenthal R, Furuse M, et al,. Contribution of tight junction proteins to ion, macromolecule, and water barrier in keratinocytes. J Invest Dermatol 2013; 133: 1161-9.
12. Proksch E, Brandner JM, Jensen JM,. The skin: an indispensable barrier. Exp Dermatol 2008; 17: 1063-72.
13. Matter K, Aijaz S, Tsapara A, et al,. Mammalian tight junctions in the regulation of epithelial differentiation and proliferation. Curr Opin Cell Biol 2005; 17: 453-8.
14. Anderson JM, Van Itallie CM, Fanning AS,. Setting up a selective barrier at the apical junction complex. Curr Opin Cell Biol 2004; 16: 140-5.
15. Aijaz S, Balda MS, Matter K,. Tight junctions: molecular architecture and function. Int Rev Cytol 2006; 248: 261-98.
16. Schneeberger EE, Lynch RD,. The tight junction: a multifunctional complex. Am J Physiol Cell Physiol 2004; 286: C1213-28.
17. Furuse M, Hata M, Furuse K, et al,. Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice. J Cell Biol 2002; 156: 1099-111.
18. Utech M, Bruwer M, Nusrat A,. Tight junctions and cell-cell interactions. Methods Mol Biol 2006; 341: 185-95.
19. Van Itallie CM, Anderson JM,. Claudins and epithelial paracellular transport. Annu Rev Physiol 2006; 68: 403-29.
20. Furuse M, Furuse K, Sasaki H, et al,. Conversion of zonulae occludentes from tight to leaky strand type by introducing claudin-2 into Madin-Darby canine kidney I cells. J Cell Biol 2001; 153: 263-72.
21. Kirschner N, Haftek M, Niessen CM, et al,. CD44 regulates tight-junction assembly and barrier function. J Invest Dermatol 2011; 131: 932-43.
22. Turksen K, Troy TC,. Permeability barrier dysfunction in transgenic mice overexpressing claudin 6. Development 2002; 129: 1775-84.
23. Kirschner N, Rosenthal R, Gunzel D, et al,. Tight junctions and differentiation-a chicken or the egg question? Exp Dermatol 2012; 21: 171-5.
24. Martinsson H, Yhr M, Enerback C,. Expression patterns of S100A7 (psoriasin) and S100A9 (calgranulin-B) in keratinocyte differentiation. Exp Dermatol 2005; 14: 161-8.
25. Niyonsaba F, Ushio H, Nakano N, et al,. Antimicrobial peptides human beta-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines. J Invest Dermatol 2007; 127: 594-604.
26. Yuki T, Haratake A, Koishikawa H, et al,. Tight junction proteins in keratinocytes: localization and contribution to barrier function. Exp Dermatol 2007; 16: 324-30.
27. Gruber R, Elias PM, Crumrine D, et al,. Filaggrin genotype in ichthyosis vulgaris predicts abnormalities in epidermal structure and function. Am J Pathol 2011; 178: 2252-63.
28. Matter K, Balda MS,. Functional analysis of tight junctions. Methods 2003; 30: 228-34.
29. Doble BW, Woodgett JR,. GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci 2003; 116: 1175-86.
30. Severson EA, Kwon M, Hilgarth RS, et al,. Glycogen synthase kinase 3 (GSK-3) influences epithelial barrier function by regulating occludin, claudin-1 and E-cadherin expression. Biochem Biophys Res Commun 2010; 397: 592-7.
31. Doble BW, Woodgett JR,. Role of glycogen synthase kinase-3 in cell fate and epithelial-mesenchymal transitions. Cells Tissues Organs 2007; 185: 73-84.
32. Gosens R, Meurs H, Schmidt M,. The GSK-3/beta-catenin-signalling axis in smooth muscle and its relationship with remodelling. Naunyn Schmiedebergs Arch Pharmacol 2008; 378: 185-91.
33. Popp T, Egea V, Kehe K, et al,. Sulfur mustard induces differentiation in human primary keratinocytes: opposite roles of p38 and ERK1/2 MAPK. Toxicol Lett 2011; 204: 43-51.
34. Zhang X, Hunt JL, Landsittel DP, et al,. Correlation of protease-activated receptor-1 with differentiation markers in squamous cell carcinoma of the head and neck and its implication in lymph node metastasis. Clin Cancer Res 2004; 10: 8451-9.
35. Kurasawa M, Maeda T, Oba A, et al,. Tight junction regulates epidermal calcium ion gradient and differentiation. Biochem Biophys Res Commun 2011; 406: 506-11.
36. Howell MD, Fairchild HR, Kim BE, et al,. Th2 cytokines act on S100/A11 to downregulate keratinocyte differentiation. J Invest Dermatol 2008; 128: 2248-58.
37. Brandner JM, Kief S, Grund C, et al,. Organization and formation of the tight junction system in human epidermis and cultured keratinocytes. Eur J Cell Biol 2002; 81: 253-63.
38. Yoshida Y, Morita K, Mizoguchi A, et al,. Altered expression of occludin and tight junction formation in psoriasis. Arch Dermatol Res 2001; 293: 239-44.
39. Anderson JM, Van IC,. Physiology and function of the tight junction. Cold Spring Harb Perspect Biol 2009; 1: a002584.
40. Milatz S, Krug SM, Rosenthal R, et al,. Claudin-3 acts as a sealing component of the tight junction for ions of either charge and uncharged solutes. Biochim Biophys Acta 2010; 1798: 2048-57.
41. Wolburg H, Wolburg-Buchholz K, Kraus J, et al,. Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme. Acta Neuropathol 2003; 105: 586-92.
42. Frame S, Cohen P,. GSK3 takes centre stage more than 20 years after its discovery. Biochem J 2001; 359: 1-16.
43. Noël A, Barrier L, Rinaldi F, et al,. Lithium chloride and staurosporine potentiate the accumulation of phosphorylated glycogen synthase kinase 3β/Tyr216, resulting in glycogen synthase kinase 3β activation in SH-SY5Y human neuroblastoma cell lines. J Neurosci Res 2011; 89: 755-63.
44. Sayas CL, Avila J, Wandosell F,. Glycogen synthase kinase-3 is activated in neuronal cells by Galpha12 and Galpha13 by Rho-independent and Rho-dependent mechanisms. J Neurosci 2002; 22: 6863-75.
45. Bhat RV, Shanley J, Correll MP, et al,. Regulation and localization of tyrosine216 phosphorylation of glycogen synthase kinase-3β in cellular and animal models of neuronal degeneration. Proc Natl Acad Sci USA 2000; 97: 11074-9.
46. Hartigan JA, Johnson GV,. Transient increases in intracellular calcium result in prolonged site-selective increases in Tau phosphorylation through a glycogen synthase kinase 3β-dependent pathway. J Biol Chem 1999; 274: 21395-401.
47. Ikeda S, Kishida S, Yamamoto H, et al,. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3β and beta-catenin and promotes GSK-3β-dependent phosphorylation of beta-catenin. EMBO J 1998; 17: 1371-84.
48. Fu Y, Zheng S, An N, et al,. β-catenin as a potential key target for tumor suppression. Int J Cancer 2011; 129: 1541-51.
49. Mullin JM, Leatherman JM, Valenzano MC, et al,. Ras mutation impairs epithelial barrier function to a wide range of nonelectrolytes. Mol Biol Cell 2005; 16: 5538-50.
50. Usatyuk PV, Natarajan V,. Role of mitogen-activated protein kinases in 4-hydroxy-2-nonenal-induced actin remodeling and barrier function in endothelial cells. J Biol Chem 2004; 279: 11789-97.
51. Gonzalez-Mariscal L, Tapia R, Chamorro D,. Crosstalk of tight junction components with signaling pathways. Biochim Biophys Acta 2008; 1778: 729-56.
52. Elias PM,. The skin barrier as an innate immune element. Semin Immunopathol 2007; 29: 3-14.
53. Schroder JM, Harder J,. Antimicrobial skin peptides and proteins. Cell Mol Life Sci 2006; 63: 469-86.
54. Glaser R, Meyer-Hoffert U, Harder J, et al,. The antimicrobial protein psoriasin (S100A7) is upregulated in atopic dermatitis and after experimental skin barrier disruption. J Invest Dermatol 2009; 129: 641-9.
55. Aberg KM, Man MQ, Gallo RL, et al,. Co-regulation and interdependence of the mammalian epidermal permeability and antimicrobial barriers. J Invest Dermatol 2008; 128: 917-25.
56. Harder J, Dressel S, Wittersheim M, et al,. Enhanced expression and secretion of antimicrobial peptides in atopic dermatitis and after superficial skin injury. J Invest Dermatol 2010; 130: 1355-64.
57. Ahrens K, Schunck M, Podda GF, et al,. Mechanical and metabolic injury to the skin barrier leads to increased expression of murine β-defensin-1, -3, and -14. J Invest Dermatol 2011; 131: 443-52.
58. Nizet V, Ohtake T, Lauth X, et al,. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 2001; 414: 454-7.